[1] Blaslov K, Naranda FS, Kruljac I, et al. Treatment approach to type 2 diabetes: Past, present and future[J]. World J Diabetes, 2018, 9(12): 209-219. [2] Maffei A, Lembo G, Carnevale D. PI3Kinases in diabetes mellitus and its related complications[J]. Int J Mol Sci, 2018, 19(12): E4098-E4113. [3] Wang R, Xu C, Zhao W, et al. Calcium and polyamine regulated calcium-sensing receptors in cardiac tissues[J]. Eur J Biochem, 2003, 270(12): 2680-2688. [4] Wang J, Li Z, Wang Y, et al. Qiliqiangxin enhances cardiac glucose metabolism and improves diastolic function in spontaneously hypertensive rats[J]. Evid Based Complement Alternat Med, 2017, 2017: 3197320-3197330. [5] 杨 锐, 贾 强, 刘小粉, 等. 硫化氢对大鼠糖尿病心肌病氧化应激及内质网应激的影响[J]. 中国应用生理学杂志, 2016, 32(1): 8-12. [6] Wang-Soo Lee, Jaetaek Kim. Diabetic cardiomyopathy: where we are and where we are going[J]. Korean J Intern Med, 2017, 32(3): 404-421. [7] 杨 帆, 韩 钰, 丛恬駪, 等. 薯蓣皂苷对大鼠心肌收缩与钠-钙交换体的影响[J]. 中国应用生理学杂志, 2016, 32(3): 209-213. [8] Riehle C, Bauersachs J. Of mice and men: models and mechanisms of diabetic cardiomyopathy[J]. Basic Res Cardiol, 2019, 114(1): 2-23. [9] Gorvin CM, Hannan FM, Cranston T, et al. Cinacalcet rectifies hypercalcemia in a patient with familial hypocalciuric hypercalcemia type 2 (FHH2) caused by a germline loss-of-function Gα11 mutation[J]. J Bone Miner Res, 2018, 33(1): 32-41. [10]Sims MW, Winter J, Brennan S, et al. PKC-mediated toxicity of elevated glucose concentration on cardiomyocyte function[J].Am J Physiol Heart Circ Physiol, 2014, 07(4): H587-H597. [11]Sharp TE 3rd, Kubo H, Berretta RM, et al. Protein kinase C inhibition with ruboxistaurin increases contractility and reduces heart size in a swine model of Hheart failure with reduced ejection fraction[J]. JACC Basic Transl Sci, 2017, 2(6): 669-683. [12]Lei CT, Wei YH, Tang H, et al. PKC-α triggers EGFR ubiquitination, endocytosis and ERK activation in podocytes stimulated with high glucose[J]. Cell Physiol Biochem, 2017, 42(1): 281-294. |